Nov 3, 2021

Media Contact:
Ilana Ostrin
212 328 3769

iostrin@hemophilia.org

“NHF applauds the CDC’s recommendation of the Pfizer-BioNTech COVID-19 vaccine for children 5 to 11 years of age. Evidence-based studies have long shown that children benefit from many safe and effective vaccines already – and now, with the COVID-19 vaccine, children and families can be more protected than ever before. For children with chronic conditions like hemophilia or other inheritable blood disorders, a COVID-19 vaccine is imperative to promoting their health and safety in these challenging times.” - Dr. Leonard A. Valentino, Pediatric Hematologist and NHF CEO/President

                                                                                                       ###

RESOURCES

- Penned Tweet

- Twitter graphic

 

 

Global Tags

Stay connected with us! Subscribe to receive the latest news on treatments, clinical trials, advocacy issues, and NHF events.